News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients L.A. McKeown August 09, 2018
News Daily News Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness Caitlin E. Cox July 16, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
News Daily News Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats Shelley Wood June 18, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
News Daily News ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World Caitlin E. Cox May 16, 2018
News Daily News LPA Variants Linked With CHD Events in Statin-Treated Patients Michael O'Riordan May 03, 2018
News Conference News SCAI 2018 PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI L.A. McKeown April 26, 2018
News Daily News Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days Yael L. Maxwell April 25, 2018
News Daily News Pulmonary Hypertension at Baseline Doesn’t Raise Mortality After TAVR Caitlin E. Cox April 20, 2018
News Daily News Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood Yael L. Maxwell April 11, 2018
News Daily News Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR Michael O'Riordan March 27, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis Todd Neale March 12, 2018
News Daily News CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease Yael L. Maxwell March 08, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Conference News ISC 2018 More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs Todd Neale January 27, 2018
News Daily News Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes Todd Neale January 17, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018